top of page

Research That Shapes the Future of Oncology

Access studies, scientific papers, and published findings advancing cancer diagnostics and care.

ACO 2022 | Actorius Innovations and Research
7 June 2022
Read More

ASCO 2022: Correlation of circulating tumor cells as a positive interventional biomarker in cancer patients

Ayurveda therapy significantly reduced CTC counts and improved quality of life in a study of 72 patients across 17 cancer types.

ESMO 2021 | Actorius Innovations and Research
9 October 2021
Read More

ESMO 2021: Validation of Cytokeratin (CK18) Protein Expression in Epithelial Cell lines and in Circulating Tumor Cells (CTCs)

Study shows significant CK18 expression variance across different cancer cell lines and CTCs, highlighting the need for regulated enumeration tools.

ASCO 2021 | Actorius Innovations and Research
8 June 2021
Read More

ASCO 2021: CTCs demonstrate a positive biomarker in head and neck squamous cell carcinoma (HNSCC) in tobacco consuming population of Bangladesh.

A study in Bangladesh found CTCs in 64% of HNSCC patients with chronic tobacco history, suggesting CTCs as a screening tool for early cancer detection.

Actorius Innovations and Research
15 July 2020
Read More

ASCO 2020: Device for the enumeration and continuous removal of circulating tumor cells in improving
overall survival of epithelial cancer patients

The POP blood fluidic device safely removes CTCs with up to 100% efficiency, offering a new therapeutic path to reduce metastasis and improve survival.

ASCO 2020 | Actorius Innovations and Research
15 March 2020
Read More

ASCO 2020: Correlation of CTCs with disease progression in Indian oral cancer patients.

In 230 OSCC patients, CTC counts correlated with cancer stage and aggressive features, proving CTCs are a reliable marker for disease stratification.

ASCO 2019 | Actorius Innovations and Research
4 June 2019
Read More

ASCO 2019: Correlation of CTCs with disease progression in Indian oral cancer patients

"OncoDiscover" is a fast, highly sensitive, and affordable (~$120) CTC nanosystem validated in 100 HNC patients to meet global medical needs.

  • Page 3

Early detection is half the battle won.

Book a Test

Simply book a CTC Test online or over a phone call and schedule a visit by our registered phlebotomists.

Sample Collection

Upon booking the CTC Test, one of our registered phlebotomists shall visit and collect 5 ml of patient’s blood sample.

Receive Report

A set of diagnostics will be run on the patient’s blood sample and the report shall be provided in 7 working days upon receipt of sample on site.

Book a test
bottom of page